v3.26.1
EQUITY (Notes)
 3 Months Ended
Mar. 31, 2026
Class of Stock [Line Items]  
Stockholders' Equity Note Disclosure [Text Block]
At-the-Market Equity Program - In February 2026, we entered into an at-the-market equity distribution agreement under which we may issue and sell shares of our common stock with an aggregate offering price up to $225 million. Sales of common stock are made by means of ordinary brokers’ transactions on the NYSE and the NYSE Texas, in block transactions or as otherwise agreed to between us and the sales agent. We are under no obligation to offer and sell common stock under the program. At March 31, 2026, we had $204.4 million of equity available for issuance under the program.

For the three months ended March 31, 2026, we executed forward sale agreements under our current at-the-market equity program for 237,307 shares of our common stock. Had we fully settled all 506,607 shares sold under our forward sale agreements, as of March 31, 2026, we would have generated net proceeds of approximately $41.5 million.

The following table summarizes our outstanding forward sale agreements at March 31, 2026:

MaturityOriginal SharesRemaining SharesForward PriceNet Proceeds Available
(Shares)(Shares)(Per share)(Thousands of dollars)
At-the-market equity program
December 31, 2026237,307 237,307 $86.16 $20,447 
Equity forward agreements
December 31, 20262,500,000 269,300 78.33 21,094 
Total forward sale agreements2,737,307 506,607 $82.00 $41,541 
Dividends Declared - In May 2026, we declared a dividend of $0.68 per share ($2.72 per share on an annualized basis) for shareholders of record as of May 18, 2026, payable on June 2, 2026.